The largest database of trusted experimental protocols

5 protocols using anti il 2

1

Isolation and Polarization of Murine CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spleens were removed from C57BL/6 mice and minced. Splenic red blood cells were removed with ammonium-chloride-potassium lysis buffer (0.15M NH4Cl, 1mM KHCO3, 0.1mM Na2 EDTA, pH 7.2∼7.4). The cells were resuspended in complete media containing RPMI 1640 supplemented with 5% fetal bovine serum and 1% antibiotics (all from Gibco, Grand Island, NY, USA). CD4+ T cells were isolated using a CD4+ T cell isolation kit (Miltenyi Biotec, San Diego, CA, USA), according to the manufacturer's protocol. The purity of isolated CD4+ T cells was assessed as > 95%. Negatively selected non-CD4+ cells were regarded as antigen-presenting cells (APCs) and irradiated at 3,000 rad before coculture. Isolated CD4+ T cells were stimulated with plate-bound anti-CD3 (0.5 mg/mL) and soluble anti-CD28 (1 mg/mL) (both from BD Biosciences) in the presence or absence of CsA (30 ng/mL) and KRGE (3 μg/mL or 10 μg/mL) for 72 h. For Th17 cell-polarizing condition, isolated CD4+ T cells were stimulated with plate-bound anti-CD3 mAb (0.5 mg/mL), soluble anti-CD28 mAb (1 mg/mL), anti-interferon (IFN) γ (2 mg/mL), anti-IL-4 (2 mg/mL), anti-IL-2 (2 mg/mL), IL-6 (20 ng/mL) (all from R&D Systems, Minneapolis, MN, USA), and transforming growth factor-beta (2 ng/mL, PeproTech, London, UK) for 72 h [16] (link), [17] (link).
+ Open protocol
+ Expand
2

Cytokine Regulation of RANKL-Mediated Osteoclastogenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human RANKL (rhRANKL) and M-CSF were purchased from R&D Systems (Minneapolis, MN, USA). NAC was obtained from Sigma Chemical Co. (St. Louis, MO, USA). Anti-human IL-17, anti-interferon γ (anti-IFN-γ), anti-IL-10, anti-IL-2, anti-IL-1β, anti-TNF-α, anti-IL-6, and anti-RANKL antibodies were purchased from R&D Systems.
+ Open protocol
+ Expand
3

Potentiating Anti-HER2/CD3-TDB Cytotoxicity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human PBMCs were co-cultured with anti-HER2/CD3-TDB (50 ng/mL) and KPL-4 for 7 days in the presence or absence of pomalidomide (1 μmol/L) and anti-IL2 (2 μg/mL; R&D Systems), followed by CD8+ T-cell purification as described above. Five thousand conditioned CD8+ T cells were re-cocultured with freshly plated SKBR3 cells (1:2 ratio) and single-agent anti-HER2/CD3-TDB (8 ng/mL). Caspase 3/7 green dye for apoptosis (Sartorius) was added in the culture. Caspase 3/7 activity was detected by IncuCyte Zoom. Images were analyzed for the number of apoptotic green objects/well.
+ Open protocol
+ Expand
4

Multiparameter Flow Cytometry Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anti-CD11b-PacBlu, αCD11b-FITC, αCD4-PE, αCD4-APC, αCD11c-APC, αCD11c-PE, αTCRvα2-PE, and αCD3ε(145-2C11) were purchased from BioLegend (San Diego, CA, USA). Anti-Ly6C-PerCP and αFoxP3-APC were products of eBioscience (San Jose, CA, USA). Anti-Ly6G-PE, αNK1.1-PE, αCD8α-PacBlu, αCD25-PE, and αCD103-Alexa Fluor 647 were products from BD Biosciences (San Jose, CA, USA). Flt3L-Fc fusion protein was purchased from BioXCell (West Lebanon, NH, USA). Anti-IL-2 was purchased from R&D Systems (Minneapolis, MN, USA). Fc-GITR-L fusion protein was produced as described previously (9 (link)).
+ Open protocol
+ Expand
5

PBMC Activation and Cytokine Blocking

Check if the same lab product or an alternative is used in the 5 most similar protocols
PBMCs were isolated by standard density gradient centrifugation protocol using Histopaque-1077 (Sigma-Aldrich, St. Louis, MO, USA). Fresh or thawed PBMC (1 × 106 cells/well) were cultured in 24-well plates with RPMI medium containing 10% fetal calf serum (FCS), 100 units/mL of penicillin, 0.1 mg/mL of streptomycin, and 2 mM of glutamine (all from Sigma-Aldrich). Cells were either left unstimulated or stimulated with soluble anti-CD3 and anti-CD28 antibodies (1 μg/mL each; BD Biosciences, Franklin Lakes, NJ, USA) and incubated for 5 days in a 37 °C incubator with humidified atmosphere and 5% CO2. Individual experiments did not mix fresh and frozen cells.
For cytokine blocking, cells were treated with one or more of the following human antibodies or antagonists (all from R&D Systems) to reach a final concentration of 10 μg/mL each: anti-IL-2 and anti-IL-2R-alpha, anti-IL-12p70, anti-IL-12/23p40, anti-IL-1β and recombinant human IL-1RA, and mouse IgG1 isotype control.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!